Pancreatic Cancer Research

ResearcherEast China Normal UniversityNo recent work listed

Weiqiang Lü

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1349-6597; OpenAlex author ID A5021219842. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer Metastasis. Last author DOI 10.3390/molecules27041209↗
  2. Triptolide suppresses pancreatic cancer cell proliferation by inhibiting hedgehog signaling pathway activity. Co-author DOI 10.1007/s11427-018-9477-3↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mingyao Liu · 1 shared paper, 2022 · strength 0.13
  2. Jiacheng He · 1 shared paper, 2022 · strength 0.13
  3. Juanjuan Feng · 1 shared paper, 2019 · strength 0.10
  4. Lin Liang · 1 shared paper, 2019 · strength 0.10
  5. Xiufeng Pang · 1 shared paper, 2019 · strength 0.10
  6. Zhenliang Sun · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.